Literature DB >> 25239621

Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ.

Marty A Fernandez1, Julia A Klutkowski1, Taylor Freret1, Michael S Wolfe2.   

Abstract

The presenilin-containing γ-secretase complex produces the amyloid β-peptide (Aβ) through intramembrane proteolysis, and >100 presenilin mutations are associated with familial early-onset Alzheimer disease (AD). The question of whether these mutations result in AD through a gain or a loss of function remains highly controversial. Mutations in presenilins increase ratios of 42- to 40-residue Aβ critical to pathogenesis, but other Aβs of 38-49 residues are also formed by γ-secretase. Evidence in cells suggests the protease first cleaves substrate within the transmembrane domain at the ϵ site to form 48- or 49-residue Aβ. Subsequent cleavage almost every three residues from the C terminus is thought to occur along two pathways toward shorter secreted forms of Aβ: Aβ49 → Aβ46 → Aβ43 → Aβ40 and Aβ48 → Aβ45 → Aβ42 → Aβ38. Here we show that the addition of synthetic long Aβ peptides (Aβ45-49) directly into purified preparations of γ-secretase leads to the formation of Aβ40 and Aβ42 whether the protease complex is detergent-solubilized or reconstituted into lipid vesicles, and the ratios of products Aβ42 to Aβ40 follow a pattern consistent with the dual-pathway hypothesis. Kinetic analysis of five different AD-causing mutations in presenilin-1 revealed that all result in drastic reduction of normal carboxypeptidase function. Altered trimming of long Aβ peptides to Aβ40 and Aβ42 by mutant proteases occurs at multiple levels, independent of the effects on initial endoproteolysis at the ϵ site, all conspiring to increase the critical Aβ42/Aβ40 ratio implicated in AD pathogenesis. Taken together, these results suggest that specific reduction of carboxypeptidase function of γ-secretase leads to the gain of toxic Aβ42/Aβ40.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Amyloid-β (AB); Carboxypeptidase; Enzyme Kinetics; Enzyme Mechanism; Intramembrane Proteolysis

Mesh:

Substances:

Year:  2014        PMID: 25239621      PMCID: PMC4223309          DOI: 10.1074/jbc.M114.581165

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

2.  gamma-Cleavage is dependent on zeta-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain.

Authors:  Guojun Zhao; Mei-Zhen Cui; Guozhang Mao; Yunzhou Dong; Jianxin Tan; Longsheng Sun; Xuemin Xu
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

3.  TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity.

Authors:  Fusheng Chen; Hiroshi Hasegawa; Gerold Schmitt-Ulms; Toshitaka Kawarai; Christopher Bohm; Taiichi Katayama; Yongjun Gu; Nobuo Sanjo; Michael Glista; Ekaterina Rogaeva; Yosuke Wakutani; Raphaëlle Pardossi-Piquard; Xueying Ruan; Anurag Tandon; Frédéric Checler; Philippe Marambaud; Kirk Hansen; David Westaway; Peter St George-Hyslop; Paul Fraser
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

4.  Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by gamma-secretase.

Authors:  Nobuto Kakuda; Satoru Funamoto; Sousuke Yagishita; Mako Takami; Satoko Osawa; Naoshi Dohmae; Yasuo Ihara
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

5.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

Authors:  M S Wolfe; W Xia; B L Ostaszewski; T S Diehl; W T Kimberly; D J Selkoe
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

6.  Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations.

Authors:  W Song; P Nadeau; M Yuan; X Yang; J Shen; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

7.  Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein.

Authors:  Toru Sato; Naoshi Dohmae; Yue Qi; Nobuto Kakuda; Hiroaki Misonou; Rie Mitsumori; Hiroko Maruyama; Edward H Koo; Christian Haass; Koji Takio; Maho Morishima-Kawashima; Shoichi Ishiura; Yasuo Ihara
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

8.  Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42.

Authors:  Satoru Funamoto; Maho Morishima-Kawashima; Yu Tanimura; Naoko Hirotani; Takaomi C Saido; Yasuo Ihara
Journal:  Biochemistry       Date:  2004-10-26       Impact factor: 3.162

9.  Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase.

Authors:  Yue Qi-Takahara; Maho Morishima-Kawashima; Yu Tanimura; Georgia Dolios; Naoko Hirotani; Yuko Horikoshi; Fuyuki Kametani; Masahiro Maeda; Takaomi C Saido; Rong Wang; Yasuo Ihara
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

10.  APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages.

Authors:  Solveig Lefranc-Jullien; Claire Sunyach; Frédéric Checler
Journal:  J Neurochem       Date:  2006-03-08       Impact factor: 5.372

View more
  54 in total

1.  Nicastrin functions to sterically hinder γ-secretase-substrate interactions driven by substrate transmembrane domain.

Authors:  David M Bolduc; Daniel R Montagna; Yongli Gu; Dennis J Selkoe; Michael S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

2.  Interrelationship between Changes in the Amyloid β 42/40 Ratio and Presenilin 1 Conformation.

Authors:  Katarzyna Marta Zoltowska; Masato Maesako; Oksana Berezovska
Journal:  Mol Med       Date:  2016-07-05       Impact factor: 6.354

Review 3.  Unraveling the complexity of γ-secretase.

Authors:  Michael S Wolfe
Journal:  Semin Cell Dev Biol       Date:  2020-01-21       Impact factor: 7.727

4.  Opposite Dysregulation of Fragile-X Mental Retardation Protein and Heteronuclear Ribonucleoprotein C Protein Associates with Enhanced APP Translation in Alzheimer Disease.

Authors:  Antonella Borreca; Katia Gironi; Giusy Amadoro; Martine Ammassari-Teule
Journal:  Mol Neurobiol       Date:  2015-06-06       Impact factor: 5.590

5.  Cleavage of amyloid precursor protein by an archaeal presenilin homologue PSH.

Authors:  Shangyu Dang; Shenjie Wu; Jiawei Wang; Hongbo Li; Min Huang; Wei He; Yue-Ming Li; Catherine C L Wong; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

6.  Enzymatic Assays for Studying Intramembrane Proteolysis.

Authors:  D M Bolduc; D J Selkoe; M S Wolfe
Journal:  Methods Enzymol       Date:  2016-12-24       Impact factor: 1.600

Review 7.  Substrate recognition and processing by γ-secretase.

Authors:  Michael S Wolfe
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-07-08       Impact factor: 3.747

8.  CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts.

Authors:  Keiichi Inoue; Luis M A Oliveira; Asa Abeliovich
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

9.  Transmembrane Substrate Determinants for γ-Secretase Processing of APP CTFβ.

Authors:  Marty A Fernandez; Kelly M Biette; Georgia Dolios; Divya Seth; Rong Wang; Michael S Wolfe
Journal:  Biochemistry       Date:  2016-09-30       Impact factor: 3.162

Review 10.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.